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Abstract
Background: Advances in computing and telecommunications have resulted in the availability of a range of online tools
for use in pathology training and quality assurance. The majority focus on either enabling pathologists to examine and
diagnose cases, or providing image archives that serve as reference material. Limited emphasis has been placed on
analysing the diagnostic process used by pathologists to reach a diagnosis and using this as a resource for improving
diagnostic performance.
Methods: The ReplaySuite is an online pathology software tool that presents archived virtual slide examinations to
pathologists in an accessible video-like format, similar to observing examinations with a double-headed microscope.
Delivered through a customised web browser, it utilises PHP (Hypertext PreProcessor) to interact with a remote
database and retrieve data describing virtual slide examinations, performed using the Virtual Pathology Slide (VPS).
To demonstrate the technology and conduct a preliminary evaluation of pathologists opinions on its potential application
in pathology training and quality assurance, 70 pathologists were invited to use the application to review their own and
other pathologists examinations of 10 needle-core breast biopsies and complete an electronic survey. 9 pathologists
participated, and all subsequently completed an exit survey.
Results: Of those who replayed an examination by another pathologist, 83.3% (5/6) agreed that replays provided an
insight into the examining pathologists diagnosis and 33.3% (2/6) reconsidered their own diagnosis for at least one case.
Of those who reconsidered their original diagnosis, all re-classified either concordant with group consensus or original
glass slide diagnosis. 77.7% (7/9) of all participants, and all 3 participants who replayed more than 10 examinations stated
the ReplaySuite to be of some or great benefit in pathology training and quality assurance.
Conclusion: Participants conclude the ReplaySuite to be of some or of great potential benefit to pathology training and
quality assurance and consider the ReplaySuite to be beneficial in evaluating the diagnostic trace of an examination. The
ReplaySuite removes temporal and spatial issues that surround the use of double-headed microscopes by allowing
examinations to be reviewed at different times and in different locations to the original examination. While the evaluation
set was limited and potentially subject to bias, the response of participants was favourable. Further work is planned to
determine whether use of the ReplaySuite can result in improved diagnostic ability.
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Diagnostic pathology involves the classification of dis-
ease, using tissues obtained during biopsies, operations or
autopsies. Classification is based on a complex set of vis-
ual features identified with the aid of a microscope. To
reach a confident diagnosis, pathologists are required to
possess well-developed searching, perception and classifi-
cation skills, acquired with the assistance of intensive one-
on-one tutoring sessions with expert pathologists. The
workloads of expert pathologists, however, often restrict
the frequency of these interactions.
While telepathology has yet to be incorporated into most
pathology labs in a clinical role [1-4], advances in com-
puting and telecommunications have resulted in the avail-
ability of a range of quality online training tools.
Designed to supplement rather than replace human tutor-
ing, such tools enable training pathologists to gain a wider
range of educational experiences. Studies have shown the
use of online training tools can improve diagnostic per-
formance, beyond what is found with human tutoring
alone [5,6].
The majority of training tools comprise interactive tutori-
als that display a limited number of pre-selected images
per case, often with accompanying notation [7-15]. How-
ever, as has been observed through the use of static telepa-
thology systems for remote diagnosis, diagnostic accuracy
is often dependent on appropriate field selection [16-21].
Novices often make errors when searching the slide [22],
so the development of the skills required to locate relevant
visual features are as important as those required for iden-
tifying them. Neither the searching nor identification
skills utilised to reach a diagnosis are assessed by conven-
tional quality assurance studies; diagnostic accuracy is
considered the principal indicator of competence.
In contrast to static systems, virtual slides (static-dynamic
hybrids) enable unrestricted examination of entire digi-
tised tissue sections [5,23-27]. This is a more accurate rep-
resentation of the microscopic environment used by
pathologists for diagnosis, and when incorporated into
training tools, can provide unrestricted but supportive
examining environments. With the cost and time required
to digitise entire slides decreasing [28], virtual slides are
finding greater application in pathology education
[5,22,26].
In order to elucidate the diagnostic process of examining
pathologists, the VPS (Virtual Pathology Slide), a virtual
slide viewer that records diagnostic behaviour, has been
developed and validated [23]. The VPS tracks each pathol-
ogist's slide examination, recording the location of, and
time spent viewing each field, and storing the data on a
remote, relational database. This data is available post-
examination for interrogation, potentially enabling the
diagnostic technique of different pathologists to be ana-
lysed and studied. While the VPS tracks user interactions
with the software, it does not utilise this data construc-
tively to provide an intrinsic benefit to the end user, the
pathologist. For this purpose, the ReplaySuite was
developed.
The ReplaySuite is a web-based, user-friendly software
tool that enables pathologists to replay virtual slide exam-
inations, performed using the Virtual Pathology Slide
(VPS) [23,29,30]. Unlike interactive tutorials and anno-
tated virtual slides, pathologists using the ReplaySuite are
able to observe the diagnostic trace of examiners, in a
manner similar to the use of a double-headed microscope.
This possesses significant potential for use in both pathol-
ogy training, where trainee pathologists may learn from
the diagnostic techniques of experts, and quality assur-
ance, for the detection and elucidation of sources of error
in participants diagnostic technique. This paper describes
the development and preliminary evaluation of the




The VPS is an interactive microscope emulator that
presents a complete digitised tissue section via the Inter-
net or CD ROM, allowing both stepwise increases of mag-
nification (16× to 2000× on standard 17" monitor) and
eight-way directional lateral-motion. During VPS exami-
nations (Fig. 1), the locations of examined fields of view
and the duration of time they were examined are
recorded. While images are being retrieved from the
remote server/CD ROM, examination data is transmitted
back to the remote VPS server, where it is stored on a rela-
tional database management system (Oracle).
Development of the ReplaySuite
The ReplaySuite is a web application that dynamically
generates HTML (HyperText Markup Language) web
pages to display images and text, using PHP, a server-side
scripting language. It communicates with an Oracle data-
base, on which all user tracking data is stored, via OCI
(Oracle Call Interface) to retrieve and write data. JavaS-
cript is used to deliver dynamic client side functionality
within the graphical user interface (GUI). The ReplaySuite
is deployed in a Microsoft Foundation Class (MFC) appli-
cation written in Visual C++, which acts as a customised
web browser. A complete description of the ReplaySuite
specification is available in the ReplaySuite technical doc-
ument [32].
Data describing an examination is retrieved from the
remote server, via server side scripting, enablingPage 2 of 15
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base. Structured Query Language (SQL) queries are
embedded within PHP, interrogating the database and
retrieving datasets. This data is used to determine which
images to request from the server or CD-ROM, and how
long to display these images. Server side scripting is also
used to dynamically generate static HTML, which provides
the GUI to display the images. During a replay, each
image viewed during the examination is displayed in the
order it was examined and for the duration it was exam-
ined. Diagnostic comments made during the examination
are displayed adjacent to the appropriate field. Client side
scripting (JavaScript) is used to dynamically alter the main
field of view locator on the slide overview, indicate the
number of seconds left until the next field of view is dis-
played and specify the upcoming action (increase/
decrease magnification/lateral movement) performed to
navigate to the next field.
Using the ReplaySuite
Users are required to login into the ReplaySuite, using a
unique username and password. In order to maintain user
anonymity, users are assigned unique VPS ID numbers.
When examination or diagnostic data is displayed, these
VPS ID numbers are used to identify the examining
pathologist. Fig. 2 shows a flowchart of user navigation
through available functionality when using the Replay-
Suite. Users may navigate between lists of examinations,
graphs of diagnostic concordance for examined cases and
examination replays. During replays, users may return to
the last viewed list of examinations, or their own exami-
nation list.
Examination lists
Upon logging in, the ReplaySuite displays an Examination
list of all VPS examinations performed by that user. Users
may also view, on demand, an Examination list of
The VPS interface used by pathologist's when examining a slideFigure 1
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examinations returning a specific diagnosis for a specific
case. Examination lists display summarised information
about each VPS examination, and for each examination
displays, from left to right, the examining pathologists
identification number (ID), the slide examined, the exam-
iners diagnosis, group consensus diagnosis for the slide
and the degree of group consensus (Fig 3). Highlighting
an examination, within an Examination list, displays the
slide overview and case history on the left of the interface.
Examination lists are interactive and provide users with
three options:
Flowchart of ReplaySuite operational functionalityigure 2
Flowchart of ReplaySuite operational functionality.Page 4 of 15
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selected slide
2. View Diagnostic concordance graphs for a selected slide
3. Replay any users examination of a selected slide
Diagnostic concordance graphs
Diagnostic concordance graphs are graphical representa-
tions of the variation in classification concluded by all
examiners of a slide. Only data relating to slides previ-
ously examined by the user may be accessed. Two graphs
are displayed; the top graph showing the variation in clas-
sification, the bottom graph the variation in sub-classifi-
cation for B5 (malignant) diagnosis (Fig. 4). The number
of examiners that concluded each diagnosis and the per-
centage concordance is also displayed in each graph.
Clicking on any bar on either graph displays the list of all
examinations of the selected slide that concluded with the
selected classification/sub-classification. The ReplaySuite
generates graphs by setting the dimensions of each bar
according to the percentage of participants it represents,
and can represent alternate scoring regimens by making
simple changes to the system.
Replaying an examination
Clicking 'View' in the Replay column on the right of an
Examination list replays an examination. During a replay,
each field of view examined is displayed in chronological
order, appearing on-screen for the duration it was origi-
nally examined. Unlike real-time observation of an exam-
ination, replays may be paused, fast-forwarded and
rewound. A slide overview, located in the top left of the
interface (Fig 5), relates the location of the magnified field
of view to the tissue section, and notes made by the
examining pathologist are displayed in the comment box.
ReplaySuite list of examinations performed by User 6Figure 3
ReplaySuite list of examinations performed by User 6.Page 5 of 15
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examining pathologist is displayed prior to a replay (Fig.
6), and a statistical analysis of the examination afterwards
(Fig. 7). This statistical analysis displays the number and
type of moves performed during the examination, the
amount of time spent, number of fields viewed and area
of tissue examined at each magnification and the specifi-
cations of the examining pathologists PC (screen resolu-
tion, colour depth and operating system).
Preliminary evaluation of the ReplaySuite
Study procedure
A preliminary study was conducted to demonstrate the
capabilities of the ReplaySuite to pathologists, and to
evaluate their opinions on its use and potential applica-
tion in training and quality assurance. Participants were
provided with open access to the 10 needlecore biopsies
examined during the VPS validation study [23], which
they were required to examine using the VPS. Once a par-
ticipant had submitted a diagnosis for a case, that partici-
pant was permitted to review their own examination data
and that of other pathologists, for that slide, using the
ReplaySuite. Participants who had previously participated
in the VPS validation study (by examining cases) were not
required to re-examine cases, and could review any
examination.
Using the ReplaySuite, participants were permitted to
view group concordance graphs, replay their own and oth-
ers examinations, view summary report forms and view
statistical breakdowns of individual examinations. Use of
the ReplaySuite was monitored and recorded to the data-
base, allowing the identification of light/heavy users and
highlighting the most frequently used functions. Table 2
provides a summary of all participant use of the
ReplaySuite. Cross-referencing VPS use (who examined
ReplaySuite variation in classification graph for slide 1Figure 4
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examinations) enabled the identification of which partic-
ipants examinations were replayed and for which slides.
Slides
The ten needle core biopsies examined during the VPS val-
idation study [23] were obtained by selecting the first
breast biopsy generated each month for a ten month
period from the Department of Pathology, Mater Miseri-
cordiae Hospital, Dublin, Ireland. Glass slide diagnosis
(clinical diagnosis) was provided by a pathologist with a
special interest in breast pathology using the Core Biopsy
Reporting Guidelines for Non-operative Diagnostic Proce-
dures and Reporting in Breast Cancer screening [31], as
used by the British National Co-ordinating Committee for
Breast Screening Pathology. Consultation was required to
finalise glass slide diagnosis on some of the cases selected.
Participants
70 pathologists were invited to participate in the study. 38
Irish participants were invited with the assistance of Pro-
fessor Peter Dervan, Mater Miscordiae Hospital, Dublin,
and the remaining invitees comprising the 32 members of
the European Working Group of Breast Screening Pathol-
ogy (EWGBSP). EWGBSP members are recognised as
expert breast pathologists in their native countries and all
member states of the European Union (EU) are repre-
sented within the group. 17 of the 70 invited participants
previously participated in the VPS validation study [23], 4
of which were members of the EWGBSP.
Exit survey
Subsequent to the study, participants completed an elec-
tronic questionnaire on their use and impressions of the
software and its potential applications. Participants were
Replaying an examination of slide 2 using the ReplaySuiteFigure 5
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with 19 statements using a Likert scale (5-point scale e.g.
strongly disagree, disagree, neutral, agree, strongly agree),
and answer Yes or No to a further 5 questions. A number
of questions were inverted to mitigate against the well-
known bias of positively phrased questions. The follow-
ing are the pertinent questions asked:
Where applicable answer yes or no to the following
• Did replaying an examination by another pathologist
with a diagnosis different to your own provide you with
an insight into why that diagnosis was concluded?
• Did replaying examinations performed by other pathol-
ogists make you reconsider your diagnosis for any slides?
Please state how much you agree with the following 
statements
• The ReplaySuite is user-friendly
• The diagnostic pathway followed by the examining
pathologist was apparent
• Being able to pause, fast-forward and rewind replays was
useful
• The information panel was not useful
Rate the benefit of using the ReplaySuite for the following 
applications
• Training
Summary report form from an examination replay using the ReplaySuiteFigure 6
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Participants were also given the opportunity to provide
open-ended feedback:
• Add any further comments, or have any additional fea-
tures you would like to see incorporated into the
ReplaySuite.
• If yes (to the question "Did you encounter technical dif-
ficulties while using the ReplaySuite?"), please state the
difficulty that occurred
Post study survey
Participants who used the ReplaySuite were resurveyed
post-study in order to determine if they regularly partici-
pated in teaching. 3 questions were asked:
• Are you, or have you been involved in providing under-
graduate medical training on a regular basis?
• Are you, or have you been involved in providing post-
graduate pathology training on a regular basis?
• If you are not currently involved but have previously




9 participants used the ReplaySuite to review examination
data. All 9 completed the electronic questionnaire, and all
but one had more than five years experience in pathology
practice, the exception possessing three years experience.
4 of the 9 participants were members of the European
Working Group of Breast Screening Pathology. Table 1
Statistical breakdown of a VPS examination using the ReplaySuiteFigure 7
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pleted the post-study survey.
Using the ReplaySuite
7 participants (77.7%) replayed at least one examination
and of these, 3 participants replayed more than 10. All
participants who replayed at least one examination agreed
or strongly agreed that the ReplaySuite was user-friendly
(Fig. 8) and 85.71% (6/7) of these agreed or strongly
agreed that being able to pause, fast-forward and rewind
an examination replay was useful. 6 of the 7 of
participants (85.71%) who replayed an examination con-
sidered replays to be of some or of great importance as a
ReplaySuite feature. 66.6% (6/9) of all participants
viewed diagnostic concordance graphs for at least 2 slides
and 2 participants (44.4%) viewed graphs for at least 7
slides.
Diagnostic re-evaluation
All participants who replayed at least one examination
agreed or strongly agreed that the diagnostic pathway of
the examining pathologist was apparent during a replay.
Of the 7 participants who replayed their own or others
examinations, 6 (85.71%) replayed another pathologists
examination. Of these 6 participants, 5 (83.3%) agreed
that it provided an insight into the examining patholo-
gists diagnosis. Of those who replayed another's examina-
tion, 2 (33.3%) reconsidered their original diagnosis, 1 re-
diagnosing concordant with group consensus and 1 re-
diagnosing concordant with original glass slide diagnosis.
After originally concluding an original diagnosis of B2
(Benign) for Slide 5, User 7 replayed his/her own exami-
nation, and then replayed an examination of Slide 5 by
User 6. This examination (User 6) concluded a diagnosis
of B5 (Malignant), concordant with group consensus.
User 10 concluded an original diagnosis for Slide 8 of B4
(Suspicion of malignancy), which concurred with group
consensus but not glass slide diagnosis, B3 (Benign but of
uncertain malignant potential). User 10 replayed their
own examination, then an examination of the same slide
that concluded the same diagnosis by User 5. Two exami-
nations concluding a B3 diagnosis were then replayed
(Users 87 and 55), concordant with glass slide diagnosis.
ReplaySuite applications
When asked to rate the potential benefit of the Replay-
Suite in pathology training, 6 out of 7 of participants who
had replayed at least one examination (85.71%) and all of
Table 1: User participation in evaluation of ReplaySuite technology
Irish EWGBSP Total
Invited to participate 38 32 70
Used ReplaySuite 5 4 9
Completed electronic survey 5 4 9

























10 10 13 7 6 3 19 35 Y
74 10 12 4 8 11 35 58 Y
55 10 11 10 1 28 69 108 Y
7 10 3 2 1 4 12 19 Y
36 10 2 1 1 0 4 6 Y
39 10 2 2 0 13 9 24 Y
102 10 1 0 1 0 4 5 Y
57 10 0 0 0 9 4 13 Y
60 2 0 0 0 0 1 1 Y
Total 92 44 26 18 68 157 269 9Page 10 of 15
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it as of some or of great benefit (Fig. 9). Of the 9 that com-
pleted the post-study survey, 7 and 8 stated they were cur-
rently, or had been involved in providing undergraduate
medical training and postgraduate pathology training on
a regular basis respectively.
When asked to rate the potential benefit of the Replay-
Suite in quality assurance, 5 out of 7 of participants who
had replayed at least one examination (71.4%) and all
participants who had replayed more than 10 examina-
tions considered it of some or of great benefit (Fig. 10).
Discussion
The VPS tracks users examinations of VPS virtual slides,
however, in isolation this data does not directly benefit
the end user. The ReplaySuite was developed to exploit the
VPS's examination tracking capabilities and utilise the
data in a manner that would have tangible benefits for
pathologists. Using a combination of server-side (PHP)
and client-side (JavaScript) open source scripting lan-
guages, it presents this data to users via an intuitive
Graphical User Interface (GUI), which was considered
easy to use by participants who replayed at least 1 exami-
nation (Fig. 8). Utilising the same technology as the VPS,
the ReplaySuite does not require the installation of any
additional software other than the customised browser,
and Internet Explorer, which is the default web browser
used by 95% of the web browser market [33].
Use of the VPS for diagnosis has already demonstrated
"substantial" diagnostic agreement between users,
88.23% of examining pathologists obtaining a Kappa of
between 0.97 and 0.65 [23]. In determining whether
pathologists could benefit from using the ReplaySuite, the
primary consideration was whether participants might
reassess their diagnosis as a result of observing VPS
examinations of the same slides by others. In the case of 2
users, observing another's examination caused them to
reconsider their original diagnosis. In contrast to the re-
diagnosis of Slide 8 by User 10: B4 (suspicion of malig-
nancy) to B3 (Benign but of uncertain malignant
potential), the difference between original and secondary
diagnosis of Slide 5 by User 7: B2 (benign) to B5 (malig-
nant) is a significant re-evaluation, one which would
result in significantly different courses of treatment in a
clinical environment. While the degree of discordance
between original diagnosis and group consensus may, in
Levels of agreement with the statement 'The ReplaySuite is User-Friendly'Figure 8
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examination (640 × 480 pixels), it may also be related to
the relative difficulty of the case; Slide 5 achieved the sec-
ond lowest group consensus (47.1%). It cannot be sug-
gested, based on these individual examples, that group
concordant re-diagnosis subsequent to ReplaySuite use
will be the rule rather than the exception. However, these
examples are worth noting, as it highlights the fact that
using the system can result in diagnostic re-evaluation.
A number of caveats should be considered when review-
ing study data, the first being small sample size. There is a
significant difference between the number of pathologists
invited to participate and those who completed the study
(9/70). While not unique in studies involving patholo-
gists use of telepathology systems, the small sample size
may be considered a potential source of error. Bamford et
al (2003) have reported similar difficulties with low par-
ticipation rates [34], however, other studies have also
attempted to evaluate telepathology tools using small
sample sizes [35]. Low participation rates may be due to a
number of factors. Bamford et al (2003) cited technical
difficulties and pathologists workloads as principal
factors for low participation [34]. System speed was high-
lighted as an issue by a number of participants during the
initial VPS evaluation study [23]. As both VPS and Replay-
Suite systems utilise similar technology, speed may be a
potential contributing factor to low participation rates for
this follow-on study. User 36 illustrated this when asked
to comment on any technical difficulties encountered
during the ReplaySuite evaluation study, stating, "It took
a great deal of time downloading image via dial up net-
work connection". User 60 also commented to this effect
regarding technical difficulties, commenting "very slow".
Secondly, it is not unreasonable to suggest that the posi-
tive evaluation of the ReplaySuite may in part be attribut-
able to bias from participants (4/9) who also previously
participated in the VPS validation study. Pathologists who
participated in both VPS and ReplaySuite studies
expressed greater satisfaction and confidence in the VPS
during the VPS validation study than pathologists who
participated only in the VPS study [23]. However during
the ReplaySuite study, these participants who participated
in both did not provide more favourable evaluation of the
ReplaySuite than participants who only participated in the
ReplaySuite study. In Figure 8, the participant who con-
sidered the ReplaySuite the most user-friendly did not par-
Levels of perceived potential benefit of the ReplaySuite in Pathology TrainingFigure 9
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participants who considered the ReplaySuite of greatest
benefit in training were participants who did not
participate in the VPS evaluation study, and both partici-
pants and non-participants in the VPS evaluation study
considered the ReplaySuite of great benefit in quality
assurance studies (Figure 10).
It also goes without question that those who participate in
studies of this nature are often early adapters and often
possess a positive bias towards new technology. This is an
issue when evaluating any new software, and in that con-
text, bias is unavoidable. 20 of the 70 participants invited
to participate had foreknowledge of the VPS, however
none, had previously seen the ReplaySuite and, therefore,
had no preconceived notions about the software.
The concept of a virtual double-headed microscope is not
new [36], however previous references to such concepts
utilised video-conferencing that was dependent on the
presence of an expert. While both pathologists were not
required to be present at the same location, they were
required to be available at the same time. In contrast,
archived VPS examinations are available at any time at any
location, irrespective of expert availability. Unlike real-
time observation of examinations, the ReplaySuite per-
mits examinations to be paused, fast-forwarded and
rewound, and images may be annotated, providing a
description of visual features within the field of view.
The benefits of various online tools and their impact on
diagnostic performance have already been highlighted,
however the ReplaySuite possesses a number of practical
advantages. Many online tools present the diagnostic
opinion of one pathologist. In contrast, the ReplaySuite
can replay examinations of the same slide by multiple
experts, illustrating a number of different diagnostic path-
ways that corroborate the same diagnostic hypothesis.
Alternatively, reviewing pathologists may observe exami-
nations that disagreed with group consensus, in order to
identify the possible sources of disagreement. This is of
particular interest for disorders that suffer from a high
degree of inter-observer variability. Additionally, interac-
tive tutorials and annotated virtual slides require consid-
erable time to create, however, individual authoring time
with the VPS/ReplaySuite is around 6 minutes, per user,
per slide.
Figures 9 &10 illustrate that the more participants used
the system, the greater potential benefit they perceived it
Levels of perceived potential benefit of the ReplaySuite in Pathology Quality AssuranceFigure 10
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participants (Users 10,55,74) who replayed more than ten
examinations considered the ReplaySuite of some or of
great potential benefit in pathology training and quality
assurance. While small sample size precludes the signifi-
cance of a relationship between heavy use and favourable
perception, it is not unreasonable to suggest that partici-
pants who fully appreciate the capabilities of the Replay-
Suite will possess a more considered opinion.
Conclusion
The objective of the study was to develop the ReplaySuite
technology, and to assess the opinions of pathologists on
its use and potential application. Participants concluded
the ReplaySuite to be of some or of great potential benefit
to pathology training and quality assurance and consid-
ered the ReplaySuite to be beneficial in evaluating the
diagnostic trace of an examination. Future evaluation of
the ReplaySuite in a larger quality assurance study and
training environment is anticipated.
One-to-one human tutoring remains, and will remain for
the foreseeable future, the pre-eminent means of nurtur-
ing pathologist's diagnostic skills. However, as factors
such as expert availability and case diversity vary, from
institution to institution, it is impossible to replicate the
same training environment universally. Supplementary
online training tools may well help to redress the balance,
providing wide access to expert pathologists and a diverse
range of cases from multiple institutions, enabling an
educational diversity often unachievable in a single insti-
tution. The ReplaySuite is a unique tool that permits
pathologists to learn from multiple experts in a manner
not possible with current tools.
Competing interests
DS and SC possess share holdings in Slidepath Ltd, a com-
pany delivering informatics solutions for use in pathology
quality assurance. DJ and PD have share options in Slide-
Path Ltd.
Authors' contributions
DS conceived the ReplaySuite and participated in the
design of the study. DJ created the ReplaySuite, carried out
the study and drafted the manuscript. SC created the VPS
and participated in the design of the database. PD partici-
pated in the design of the ReplaySuite and provided a
pathologist's insight.
Acknowledgements
The Authors would like to thank the Health Research Board, Ireland for 
their funding, and the pathologists who participated in this study.
References
1. Mairinger T, Netzer TT, Schoner W, Gschwendtner A: Pathologists
attitudes to implementing telepathology. J Telemed Telecare
1998, 4:41-46.
2. Della Mea V, Cortolezzis D, Beltrami CA: The economics of
telepathology – a case study. J Telemed Telecare 2000, 6(Suppl
1):S168-169.
3. Steinberg DM, Ali SZ: Application of virtual microscopy in clin-
ical cytopathology. Diagn Cytopathol 2001, 25:389-396.
4. Demichelis F, Barbareschi M, Dalla Palma P, Forti S: The virtual
case: a new method to completely digitize cytological and
histological slides. Virchows Arch 2002, 441:159-164.
5. Dee FR, Lehman JM, Consoer D, Leaven T, Cohen MB: Implemen-
tation of virtual microscope slides in the annual pathobiology
of cancer workshop laboratory. Hum Pathol 2003, 34:430-436.
6. Heidger PM Jr, Dee F, Consoer D, Leaven T, Duncan J, Kreiter C:
Integrated approach to teaching and testing in histology
with real and virtual imaging. Anat Rec 2002, 269:107-112.
7. College of Medicine, University of Illinois at Urbana-Cham-
paign. Atlas of histology  [http://www.med.uiuc.edu/histo/small/
atlas/index.htm]
8. The WHO/ISUP Consensus Classification of Urothelial
(Transitional Cell) Neoplasms tutorial and proficiency test
[http://162.129.103.34/bladder]
9. Kronz JD, Silberman MA, Allsbrook WC Jr, Bastacky SI, Burks RT,
Cina SJ, Mills SE, Ross JS, Sakr WA, Tomaszewski JE, True LD,
Ulbright TM, Weinstein MW, Yantiss RK, Young RH, Epstein JI:
Pathology Resident's Use of a web-based tutorial to improve
Gleason grading of prostate carcinoma on needle biopsies.
Hum Pathol 2000, 31:1044-50.
10. University of Kansas Medical Center, Basic Histopathology
website  [http://www.kumc.edu/instruction/medicine/anatomy/
histoweb/path/path.htm]
11. Loyola University, Chicago. Dermatology Medical Education
Website  [http://www.meddean.luc.edu/lumen/MedEd/medicine/
dermatology/melton/skinlsn/sknlsn.htm]
12. School of Anatomy and Human Biology – The University of
Western Australia. Blue Histology  [http://
www.lab.anhb.uwa.edu.au/mb140/Big/Big.htm]
13. Ponton L: Break IT – The Breast Cancer Pathology Informa-
tion Kit. Breast Cancer Res 1999, 1:0003.
14. The Johns Hopkins Medical Institutions, Department of
Pathology, Division of Hematopathology. Flow cytometry
tutorial  [http://162.129.103.34/leuk/toc.htm]
15. The virtual hospital atlas of liver pathology  [http:www.vh.org/
adult/provider/pathology/LiverPathology/Text/AtlasLiv erPathol-
ogy.html]
16. Weinstein LJ, Epstein JI, Edlow D, Westra WH: Static image anal-
ysis of skin specimens: the application of telepathology to
frozen section evaluation. Hum Pathol 1997, 28:30-35.
17. Halliday BE, Bhattacharyya AK, Graham AR, Davis JR, Leavitt SA,
Nagle RB, McLaughlin WJ, Rivas RA, Martinez R, Krupinski EA, Wein-
stein RS: Diagnostic accuracy of an international static-imag-
ing telepathology consultation service. Hum Pathol 1997,
28:17-21.
18. Weinstein MH, Epstein JI: Telepathology diagnosis of prostate
needle biopsies. Hum Pathol 1997, 28:22-29.
19. Raab SS, Zaleski MS, Thomas PA, Niemann TH, Isacson C, Jensen CS:
Telecytology-diagnostic accuracy in cervical-vaginal smears.
Am J Clin Pathol 1996, 105:599-603.
20. Weinberg DS, Allaert FA, Dusserre P, Drouot F, Retailliau B, Welch
WR, Longtine J, Brodsky G, Folkerth R, Doolittle M: Telepathology
diagnosis by means of digital still images: an international
validation study. Hum Pathol 1996, 27:111-118.
21. Walter-Reed Army Medical Center. Pathology and area lab-
oratory sciences: pathology to go!  [http://
www.wramc.amedd.army.mil/departments/pathology/links.htm]
22. Crowley RS, Naus GJ, Stewart J, Friedman CP: Development of
Visual Diagnostic Expertise in Pathology. An Information
Processing Study. J Am Med Inform Assoc 2003, 10:39-51.
23. Costello SP, Johnston DJ, Dervan PA, O' Shea DG: Development
and Evaluation of the Virtual Pathology Slide: A New Tool in
Telepathology. J Med Internet Res 2003, 5:e11.
24. Bacus Laboratories Inc. Microscope imaging and virtual
microscopy products for pathology, research and medical
education  [http://www.bacuslabs.com/]Page 14 of 15
(page number not for citation purposes)
BMC Medical Informatics and Decision Making 2005, 5:10 http://www.biomedcentral.com/1472-6947/5/10Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
25. Fairfield Imaging. Software for digital pathology  [http://
www.fairfield-imaging.co.uk/]
26. Virtual microscope pathology images for pregraduate stu-
dents of pathology and dermatology: Melanocytic lesions
[http://atlases.muni.cz/virtualmicr/melanocyte/melanocyte.html]
27. Steinberg DM, Ali SZ: Application of virtual microscopy in clin-
ical cytopathology. Diagn Cytopathol 2001, 25:389-396.
28. Aperio Technologies. Virtual microscopy solutions for anal-
ysis and discovery  [http://www.aperio.com/home.asp]
29. Costello SP, Johnston DJ, Dervan PA, O'Shea DG: The virtual
pathology slide: a new internet telemicroscopy tool for trac-
ing the process of microscopic diagnosis and evaluating
pathologist behaviour [Abstract]. Arch Pathol Lab Med 2002,
126:781-802.
30. Costello SP, Johnston DJ, Dervan PA, O' Shea DG: Evaluation of
the virtual pathology slide: using breast needle core biopsy
specimens [Abstract]. Br J Cancer 2002:S1-34.
31. Non-operative Diagnosis Subgroup of the National Coordi-
nating Group for Breast Screening Pathology. Guidelines for
non-operative diagnostic procedures and reporting in breast
cancer screening  [http://www.cancerscreening.nhs.uk/breast
screen/publications/nhsbsp50.pdf]
32. ReplaySuite Technical Document  [http://www.telepathol
ogy.dcu.ie/rstechdoc.pdf]
33. Internet Browser market share  [http://www.websidestory.com]
34. Bamford WM, Rogers N, Kassam M, Rashbass J, Furness PN: The
development and evaluation of the UK national telepathol-
ogy network. Histopathology 2003, 42:110-9.
35. Lee ES, Kim IS, Choi JS, Yeom BW, Kim HK, Han JH, Lee MS, Leong
AS: Accuracy and reproducibility of telecytology diagnosis of
cervical smears. A tool for quality assurance programs. Am J
Clin Pathol 2003, 119:356-60.
36. Furness P, Rashbass J: The virtual double-headed microscope:
telepathology for all? Histopathology 2000, 36:182-183.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1472-6947/5/10/prepubPage 15 of 15
(page number not for citation purposes)
